EPHB6 augments both development and drug sensitivity of triple-negative breast cancer tumours

Triple-negative breast cancer (TNBC) tumours that lack expression of oestrogen, and progesterone receptors, and do not overexpress the HER2 receptor represent the most aggressive breast cancer subtype, which is characterised by the resistance to therapy in frequently relapsing tumours and a high rat...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Oncogene
Main Authors: Toosi, Behzad M., El Zawily, Amr, Truitt, Luke, Shannon, Matthew, Allonby, Odette, Babu, Mohan, DeCoteau, John, Mousseau, Darrell, Ali, Mohsin, Freywald, Tanya, Gall, Amanda, Vizeacoumar, Frederick S., Kirzinger, Morgan W., Geyer, C. Ronald, Anderson, Deborah H., Kim, TaeHyung, Welm, Alana L., Siegel, Peter, Vizeacoumar, Franco J., Kusalik, Anthony, Freywald, Andrew
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2018
Teme:
Article
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC6062499/
https://ncbi.nlm.nih.gov/pubmed/29700392
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41388-018-0228-x
Oznake: Označite
Brez oznak, prvi označite!

Podobne knjige/članki